Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2026 ∙ Zarro, M. Bashlakova, K. Dellisanti, B. Brunone, S. Villari, P. De Vito, C. Rosso, A.

Immunogenicity and safety of Ebola vaccines in children: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Ebola
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Boene, J. L. Campos, L. R. Carpi, G. C. Muhawenimana, M. Machado, S. H. de Deus, N. Bauhofer, A. F. L.

Immunogenicity and safety of novel oral polio vaccine type 2 (nOPV2) in pediatric populations: a systematic review and Bayesian meta-analysis

  • Newborn
  • Children
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Hussain, M. Hassan, M. Athar, M. Khan, S. Azam, M. T. Rathi, D. Nawaz, J.

Immunogenicity and safety of Sabin-strain inactivated poliovirus vaccine in infants: a systematic review and meta-analysis

  • Newborn
  • Children
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Chen, X. Tavlian, S. Carville, K. S. Tellioglu, N. Spirkoska, V. Carvalho, N. Price, D. J. Campbell, P. T. McVernon, J.

Impact of CRM197-based conjugate vaccines, schedules, and regions on pneumococcal immunogenicity in young children: systematic review

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Borlini, S. Pennisi, F. Pinto, A. De Ponti, E. D’Amelio, A. C. Signorelli, C.

Impact of pharmacy-based interventions on vaccination coverage among vulnerable and underserved populations: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Tetanus
  • Diphtheria
  • Pertussis
  • Hepatitis B
  • Herpes zoster
  • Hepatitis A
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Measles
  • Mumps
  • Rubella
  • Human papillomavirus (HPV)
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Apata, B. O. Tupe, A. H. Akeju, O. Wilson, K. L.

Impact of Social Media on HPV Vaccine Knowledge and Attitudes Among Adolescents and Young Adults: A Systematic Literature Review

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Ellingson, M. K. Sudarsanam, V. Goddard, K. Tomar, A. Nachman, S. Brewer, N. T.

Impact of standing orders on vaccine uptake: A systematic review

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Kerth, J. L. Kurz, C. Obitz, J. Vogel, T. Mayatepek, E. Dzietko, M.

In-hospital rotavirus vaccination in premature and medically ill infants: a systematic review of uptake and safety

  • Newborn
  • Rotavirus
  • Coverage
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Gilmore, A. C. Liang, Y. Galbreath, I. M. Hobbs, L. K. LaRocco, A. M. Ludeman, E. M. Fitzpatrick, M. C. Friedman, L. Warshawsky, B. F. Kwong, J. C. Neuzil, K. M. Ortiz, J. R.

Indirect Influenza Vaccine Effectiveness Under Randomized Conditions: A Systematic Review and Meta-Analysis

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Jeong, H. S. Kim, H. Y.

Influenza Vaccine Effectiveness in Korea: A Systematic Review and Meta-Analysis of Real-World Evidence from the Past Decade

  • Western Pacific
  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...